Logo image
Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia
Journal article   Peer reviewed

Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia

David J. Adelstein, John A. Ridge, David M. Brizel, F. Christopher Holsinger, Bruce H. Haughey, Brian O'Sullivan, Eric M. Genden, Jonathan J. Beitler, Gregory S. Weinstein, Harry Quon, …
Head & neck, Vol.34(12), pp.1681-1703
12/2012
DOI: 10.1002/hed.23136
PMCID: PMC7721598
PMID: 23015475
url
https://hdl.handle.net/2027.42/94490View
Open Access

Abstract

Recent advances now permit resection of many pharyngeal tumors through the open mouth, an approach that can greatly reduce the morbidity of surgical exposure. These transoral techniques are being rapidly adopted by the surgical community and hold considerable promise. On November 67, 2011, the National Cancer Institute sponsored a Clinical Trials Planning Meeting to address how to further investigate the use of transoral surgery, both in the good prognosis human papillomavirus (HPV)initiated oropharyngeal cancers, and in those with HPV-unrelated disease. The proceedings of this meeting are summarized. (c) 2012 Wiley Periodicals, Inc. Head Neck, 2012
Life Sciences & Biomedicine Otorhinolaryngology Science & Technology Surgery

Details

Metrics

2 Record Views
Logo image